BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20203165)

  • 1. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.
    Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure.
    Sawires HK; Mohamed WA; Schaalan MF
    Iran J Kidney Dis; 2012 Sep; 6(5):366-72. PubMed ID: 22976263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
    Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
    Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
    van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of low- or high-flux haemodialysis and online haemodiafiltration on inflammatory markers and lipid profile in chronic haemodialysis patients.
    Akoglu H; Dede F; Piskinpasa S; Falay MY; Odabas AR
    Blood Purif; 2013; 35(4):258-64. PubMed ID: 23689379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
    Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
    Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
    Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
    Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.